150 results
Page 6 of 8
8-K
EX-99.1
nj3uflb6jfqzp10
23 Oct 18
Results of Operations and Financial Condition
8:15am
8-K
EX-99.1
0oj0z
26 Jul 18
Results of Operations and Financial Condition
7:05am
8-K
EX-99.1
b910mvph3wr5drx
2 Jul 18
Regulation FD Disclosure
7:14am
8-K
EX-99.1
nlp x4g62
26 Apr 18
Results of Operations and Financial Condition
12:00am
8-K
EX-99.1
20wtxp uus96xu07
27 Nov 17
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.1
kcpe0nhn1hfpfqebc0
20 Oct 16
Regulation FD Disclosure
12:00am
8-K
EX-99.1
ldcw9
9 Mar 15
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.1
zodky8y iq
24 Feb 15
Results of Operations and Financial Condition
12:00am
8-K
EX-99.1
1fzx67 5th7
29 Oct 14
Alkermes PLC Reports Third Quarter 2014 Financial Results
12:00am
8-K
EX-99.1
55tu 9aznl7i
31 Jul 14
Alkermes PLC Reports Second Quarter 2014 Financial Results
12:00am
8-K
EX-99.1
e3bwwluy
8 Apr 14
Alkermes Announces Positive Topline Results from Pivotal Phase 3 Study of Aripiprazole Lauroxil for Treatment of Schizophrenia
12:00am
8-K
EX-99.1
tqjz24e
27 Feb 14
Results of Operations and Financial Condition
12:00am
10-KT
qeycokt
27 Feb 14
Annual report (with FYE transition)
12:00am
424B5
3v5tesawz di
13 Jan 14
Prospectus supplement for primary offering
12:00am
8-K
EX-99.1
rn740vw
13 Jan 14
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.1
nukh9bdeg4oip
8 Jan 14
Alkermes Announces Advances with Its Late-stage CNS Pipeline
12:00am
8-K
EX-99.1
sb2 rdcs8hj3r3pt
6 Jan 14
Alkermes Announces Notice of Allowance of U.S. Patent for a Novel Fumarate Prodrug for Multiple Sclerosis
12:00am